Treatment of ApcMin/+Nlrc3−/− mice with a PI3K/mTOR inhibitor reduced organoid-forming capacity, tumour burden and phosphorylation of S6 kinase, indicating a mechanism by which NLRC3 maintains homeostasis and limits tumourigenesis. Here, NLRC3 is linked to neoplasm.